These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 26837274)

  • 1. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
    Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
    Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
    Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
    Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY
    Ann Surg Oncol; 2013 Feb; 20(2):653-9. PubMed ID: 22956067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
    Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
    Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
    O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Safety of Robot Thyroid Surgery for Papillary Thyroid Carcinoma: A Comparative Study of Robot versus Open Thyroid Surgery Using Inverse Probability of Treatment Weighting.
    Sung TY; Yoon JH; Han M; Lee YH; Lee YM; Song DE; Chung KW; Kim WB; Shong YK; Hong SJ
    PLoS One; 2016; 11(6):e0157345. PubMed ID: 27285846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
    Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
    Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
    Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
    World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer.
    Kim SJ; Park SY; Lee YJ; Lee EK; Kim SK; Kim TH; Jung YS; Ryu J; Myong JP; Chung KW
    Ann Surg Oncol; 2014 Jun; 21(6):1884-90. PubMed ID: 24515566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.